We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
-2.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$34.1B
AUM Growth
-$2.63B
Cap. Flow
-$362M
Cap. Flow %
-1.06%
Top 10 Hldgs %
13.14%
Holding
2,315
New
186
Increased
813
Reduced
981
Closed
182

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$283M
2
MDT icon
Medtronic
MDT
+$96M
3
PM icon
Philip Morris
PM
+$80.4M
4
UPS icon
United Parcel Service
UPS
+$75.5M
5
D icon
Dominion Energy
D
+$74.2M

Top Sells

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$178M
2
GIS icon
General Mills
GIS
+$158M
3
XOM icon
ExxonMobil
XOM
+$138M
4
NOW icon
ServiceNow
NOW
+$96M
5
KEYS icon
Keysight
KEYS
+$72.1M

Sector Composition

Rank Sector Weight
1 Healthcare 23.14%
2 Financials 15.14%
3 Technology 13.55%
4 Consumer Discretionary 8.1%
5 Consumer Staples 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKA icon
2001
a.k.a. Brands
AKA
$119M
$1K ﹤0.01%
+45
New +$1.16K
ALLO icon
2002
Allogene Therapeutics
ALLO
$594M
$1K ﹤0.01%
43
ANIP icon
2003
ANI Pharmaceuticals
ANIP
$1.66B
$1K ﹤0.01%
8
-13
-62% -$445
APEI icon
2004
American Public Education
APEI
$819M
$1K ﹤0.01%
126
+15
+14% +$186
ATOS icon
2005
Atossa Therapeutics
ATOS
$23.7M
$1K ﹤0.01%
45
AVA icon
2006
Avista
AVA
$3.04B
$1K ﹤0.01%
34
-4
-11% -$167
AVD icon
2007
American Vanguard Corp
AVD
$66.7M
$1K ﹤0.01%
1
-469
-100% -$9.78K
AYTU icon
2008
AYTU BioPharma
AYTU
$21.4M
$1K ﹤0.01%
289
-47
-14% -$357
BGC icon
2009
BGC Group
BGC
$5.77B
$1K ﹤0.01%
6
+4
+200% +$15
BLND icon
2010
Blend Labs
BLND
$322M
$1K ﹤0.01%
+2
New +$6
BNGO icon
2011
Bionano Genomics
BNGO
$18.4M
-1
Closed -$1.32K
BTU icon
2012
Peabody Energy
BTU
$3.25B
$1K ﹤0.01%
8
-555
-99% -$12.5K
CABA icon
2013
Cabaletta Bio
CABA
$441M
$1K ﹤0.01%
1,591
+434
+38% +$523
CDRE icon
2014
Cadre Holdings
CDRE
$1.18B
$1K ﹤0.01%
+25
New +$612
CERS icon
2015
Cerus
CERS
$504M
$1K ﹤0.01%
2
+1
+100% +$5
CIVB icon
2016
Civista Bancshares
CIVB
$573M
$1K ﹤0.01%
52
CLDT
2017
Chatham Lodging
CLDT
$608M
$1K ﹤0.01%
+144
New +$1.73K
CLSD
2018
DELISTED
Clearside Biomedical
CLSD
$1K ﹤0.01%
+5
New +$110
COMP icon
2019
Compass
COMP
$7.95B
$1K ﹤0.01%
+3
New +$11
COUR icon
2020
Coursera
COUR
$1.4B
$1K ﹤0.01%
+66
New +$875
CRC icon
2021
California Resources
CRC
$5.12B
$1K ﹤0.01%
20
-106
-84% -$4.61K
CRSR icon
2022
Corsair Gaming
CRSR
$1.45B
$1K ﹤0.01%
1
-1,336
-100% -$19.2K
CSV icon
2023
Carriage Services
CSV
$513M
$1K ﹤0.01%
1
-39
-98% -$1.46K
CTBI icon
2024
Community Trust Bancorp
CTBI
$1.41B
$1K ﹤0.01%
32
CTS icon
2025
CTS Corp
CTS
$1.62B
$1K ﹤0.01%
10
-51
-84% -$2.05K

Similar funds

Federated Hermes's Q3 2022 Portfolio in Review

As of Q3 2022, Federated Hermes held 2,315 positions worth $34.1B, down 7.2% from $36.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Federated Hermes's Q3 2022 filing shows 186 new, 813 increased, 981 reduced and 182 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M. The largest sale was Cardinal Health, an estimated $178M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.

  • Federated Hermes's largest Q3 2022 buy was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M.
  • Federated Hermes added most to JPMorgan Chase in Q3 2022, an estimated $283M increase.
  • Federated Hermes's biggest Q3 2022 reduction was Cardinal Health, cutting an estimated $178M.
  • Federated Hermes fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $69.1M.
  • Federated Hermes's ten largest holdings make up 13% of its $34.1B portfolio in Q3 2022.
  • Federated Hermes opened 186 new positions and closed 182 in Q3 2022.
  • Federated Hermes's portfolio value fell 7.2% quarter-over-quarter to $34.1B.

Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.